-- 
Ampal-American, Brainsway, Harel, Teva: Israeli Equity Preview

-- B y   S h a r o n   W r o b e l
-- 
2011-05-29T06:28:13Z

-- http://www.bloomberg.com/news/2011-05-29/ampal-american-brainsway-harel-teva-israeli-equity-preview.html
The following stocks may rise or fall
in Israeli markets. Stock symbols are in parentheses after the
company names and prices are from the last close unless
otherwise stated.  The TA-25 Index rose 1.1 percent to 1,237.89 in Tel Aviv.  Ampal-American Israel (AMPL)  Corp: The owner of a 12.5
percent stake in East Mediterranean Gas Co. said its series A, B
and C bonds were lowered to Baa3 from Baa1 with a negative
outlook and were removed from “watchlist” at Moody’s Midroog.
Ampal-American gained 1.5 percent to 4.277 shekels.  Brainsway Ltd. (BRIN)  : The maker of devices expects to
price a planned U.S. offering of 1 million shares at $9 to $11
each. The shares are being sold “together with” 667,000
warrants. Brainsway added 0.2 percent to 31.63 shekels.  Dexia Israel Bank Ltd. (DXIL IT): The mortgage lender said
first-quarter profit rose to 9.8 million shekels ($2.8 million)
from 9.2 million shekels a year earlier. Dexia advanced 2
percent to 652.40 shekels.  Hadera Paper Ltd. (HAP)  : The manufacturer of paper and
paper products filed a shelf prospectus covering ordinary
shares, debt securities and warrants. Hadera rose 4.3 percent to
246.10 shekels.  Harel Insurance Investments & Financial Services Ltd. (HARL)  : The insurer said first-quarter net income fell to 109.6
million shekels from 181.4 million shekels a year earlier. Harel
increased 3 percent to 177.60 shekels.  Itamar Medical Ltd. (ITMR)  : The maker of medical-
diagnostic equipment reported a first-quarter loss of $1.4
million after net income of $2 million a year ago. Itamar
Medical increased 0.9 percent to 2.07 shekels.  Teva Pharmaceutical Industries Ltd. (TEVA)  : The U.S.
 Food and Drug Administration  approved the world’s largest maker
of generic drugs’ version of Viiv Healthcare Co.’s Combivir
tablets to treat HIV. Teva fell 0.4 percent to 170.50 shekels.  To contact the reporter on this story:
Sharon Wrobel in  Tel Aviv  at 
 swrobel4@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  